Oxygen Biotherapeutics Inc.’s (OXBO.OB) Upstanding Spinal Cord Oxygen Therapy featured in Major Medical Publication
According to the National Spinal Cord Injury Statistical Center, approximately 12,000 cases of spinal cord injury occur each year. The No. 1 cause of spinal cord injury is motor vehicle crashes, accounting for 42 percent of reported injuries. Acts of violence, such as gunshot wounds, and recreational sporting activities follow, respectively. Oxygen Biotherapeutics Inc. (OTCBB: OXBO) engages in the commercialization of oxygen therapeutics and related pharmaceuticals and medical devices. The company today announced that Oxycyte, the company’s perfluorocarbon (PFC) oxygen carrier, was featured in the August 2008 edition of the "Journal of Neurosurgery: Spine." The article explains how Oxycyte can…